Our investigations indicate that (i) increased APE1 protein levels in NSCLC biopsy tissue are correlated with a decreased sensitivity to chemotherapy and (ii) sAPE1 is significantly elevated in NSCLC patients and enhances diagnostic power of carcinoembryonic antigen (CEA). Here, CEACAM5 is linked to non-small cell lung carcinoma.